Targeted Drug Delivery via the Use of ECM-Mimetic Materials

The use of drug delivery vehicles to improve the efficacy of drugs and to target their action at effective concentrations over desired periods of time has been an active topic of research and clinical investigation for decades. Both synthetic and natural drug delivery materials have facilitated loca...

Full description

Bibliographic Details
Main Authors: Jeongmin Hwang, Millicent O. Sullivan, Kristi L. Kiick
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fbioe.2020.00069/full
id doaj-83dab4fb88ae4b54a13c10d99ac14880
record_format Article
spelling doaj-83dab4fb88ae4b54a13c10d99ac148802020-11-25T01:01:15ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852020-02-01810.3389/fbioe.2020.00069502976Targeted Drug Delivery via the Use of ECM-Mimetic MaterialsJeongmin Hwang0Millicent O. Sullivan1Millicent O. Sullivan2Kristi L. Kiick3Department of Biomedical Engineering, University of Delaware, Newark, DE, United StatesDepartment of Biomedical Engineering, University of Delaware, Newark, DE, United StatesDepartment of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE, United StatesDepartment of Materials Science and Engineering, University of Delaware, Newark, DE, United StatesThe use of drug delivery vehicles to improve the efficacy of drugs and to target their action at effective concentrations over desired periods of time has been an active topic of research and clinical investigation for decades. Both synthetic and natural drug delivery materials have facilitated locally controlled as well as targeted drug delivery. Extracellular matrix (ECM) molecules have generated widespread interest as drug delivery materials owing to the various biological functions of ECM. Hydrogels created using ECM molecules can provide not only biochemical and structural support to cells, but also spatial and temporal control over the release of therapeutic agents, including small molecules, biomacromolecules, and cells. In addition, the modification of drug delivery carriers with ECM fragments used as cell-binding ligands has facilitated cell-targeted delivery and improved the therapeutic efficiency of drugs through interaction with highly expressed cellular receptors for ECM. The combination of ECM-derived hydrogels and ECM-derived ligand approaches shows synergistic effects, leading to a great promise for the delivery of intracellular drugs, which require specific endocytic pathways for maximal effectiveness. In this review, we provide an overview of cellular receptors that interact with ECM molecules and discuss examples of selected ECM components that have been applied for drug delivery in both local and systemic platforms. Finally, we highlight the potential impacts of utilizing the interaction between ECM components and cellular receptors for intracellular delivery, particularly in tissue regeneration applications.https://www.frontiersin.org/article/10.3389/fbioe.2020.00069/fulltargeted drug deliveryextracellular matrixhydrogelECM ligandECM cell receptors
collection DOAJ
language English
format Article
sources DOAJ
author Jeongmin Hwang
Millicent O. Sullivan
Millicent O. Sullivan
Kristi L. Kiick
spellingShingle Jeongmin Hwang
Millicent O. Sullivan
Millicent O. Sullivan
Kristi L. Kiick
Targeted Drug Delivery via the Use of ECM-Mimetic Materials
Frontiers in Bioengineering and Biotechnology
targeted drug delivery
extracellular matrix
hydrogel
ECM ligand
ECM cell receptors
author_facet Jeongmin Hwang
Millicent O. Sullivan
Millicent O. Sullivan
Kristi L. Kiick
author_sort Jeongmin Hwang
title Targeted Drug Delivery via the Use of ECM-Mimetic Materials
title_short Targeted Drug Delivery via the Use of ECM-Mimetic Materials
title_full Targeted Drug Delivery via the Use of ECM-Mimetic Materials
title_fullStr Targeted Drug Delivery via the Use of ECM-Mimetic Materials
title_full_unstemmed Targeted Drug Delivery via the Use of ECM-Mimetic Materials
title_sort targeted drug delivery via the use of ecm-mimetic materials
publisher Frontiers Media S.A.
series Frontiers in Bioengineering and Biotechnology
issn 2296-4185
publishDate 2020-02-01
description The use of drug delivery vehicles to improve the efficacy of drugs and to target their action at effective concentrations over desired periods of time has been an active topic of research and clinical investigation for decades. Both synthetic and natural drug delivery materials have facilitated locally controlled as well as targeted drug delivery. Extracellular matrix (ECM) molecules have generated widespread interest as drug delivery materials owing to the various biological functions of ECM. Hydrogels created using ECM molecules can provide not only biochemical and structural support to cells, but also spatial and temporal control over the release of therapeutic agents, including small molecules, biomacromolecules, and cells. In addition, the modification of drug delivery carriers with ECM fragments used as cell-binding ligands has facilitated cell-targeted delivery and improved the therapeutic efficiency of drugs through interaction with highly expressed cellular receptors for ECM. The combination of ECM-derived hydrogels and ECM-derived ligand approaches shows synergistic effects, leading to a great promise for the delivery of intracellular drugs, which require specific endocytic pathways for maximal effectiveness. In this review, we provide an overview of cellular receptors that interact with ECM molecules and discuss examples of selected ECM components that have been applied for drug delivery in both local and systemic platforms. Finally, we highlight the potential impacts of utilizing the interaction between ECM components and cellular receptors for intracellular delivery, particularly in tissue regeneration applications.
topic targeted drug delivery
extracellular matrix
hydrogel
ECM ligand
ECM cell receptors
url https://www.frontiersin.org/article/10.3389/fbioe.2020.00069/full
work_keys_str_mv AT jeongminhwang targeteddrugdeliveryviatheuseofecmmimeticmaterials
AT millicentosullivan targeteddrugdeliveryviatheuseofecmmimeticmaterials
AT millicentosullivan targeteddrugdeliveryviatheuseofecmmimeticmaterials
AT kristilkiick targeteddrugdeliveryviatheuseofecmmimeticmaterials
_version_ 1725209926421184512